Angioblast, Mesoblast, and the Medical Applications of Mesenchymal Precursor Cells (EP6)
Quick Links
Description
You are Watching:
Angioblast, Mesoblast, and the Medical Applications of Mesenchymal Precursor Cells
AngioBlast Systems (Private, NY, USA) and Mesoblast (ASX:MSB), Melbourne, Australia) are the two companies featured in this episode of the Stem Cell Review. Michael Schuster presents the companies' mesenchymal precursor cells isolated from bone marrow, for allogeneic treatment. On the one hand, AngioBlast focuses on cardio vascular indications (heart failure, heart attack) with a phase 2 trial that is 2/3rds of the way, and has an encouraging efficacy profile. On the other hand, Mesoblast is focused on orthopedic indications (mainly bone regeneration and cartilage repair) with an equally promising pilot study in long bone fractures that don't heal over time.
This is the Episode 6 of the Stem Cell Review, aired on November 12th, 2009
Related Videos
Stem Cell Review: Mesenchymal Stem Cells and Connective Disorders (EP6) (9:32)
<all>Gordana Vunjak-Novakovic of Columbia University gives us an explanation of what mesenchymal stem cells are; adult stem cells that are present in many organs and tissues, and that drive tissue repair. The main sources of mesenchymal stem cells are bone marrow and fat (adipose tissue), although they can be found lesser quantities in muscle, blood, heart, liver, and other tissues. Mesenchymal stem cells can be used to regenerate many different types of tissue, but the most promising clinical applications are in bone, cartilage, ligaments, muscle, neural cells, and striated muscles. Mesenchymal stem cells are thought to repair the heart muscles through revascularization and recruitment of repair cells, but the data does not yet show that they can convert into heart muscle. In a future outlook, Gordana shares with us what she thinks is in the near future of mesenchymal stem cells: well defined cells that can be differentiated predictably, understanding the importance of cell origin on clinical outcome, new FDA friendly delivery routes, more effective functional markers and monitoring, and increasing interdisciplinary collaboration.
Stem Cell Review: Mesenchymal Stem Cells and Connective Disor...
Stem Cell Review: Tools for Drug Screening (EP4) (16:13)
<all>Researchers are using stem cells as tools for disease study, drug screening, clinical trial strategy, and personalized medicine. The induced Pluripotent Stem cell (iPS) is giving us a chance to rethink the way we are developing new drugs. These iPS cells are usually created from somatic cells (such as skin), and not embryos or adult stem cells. In creating iPS from patients' diseased cells, scientists can study the disease in vitro, looking for disease phenotypes, applying microenvironmental stress, and testing new drugs. Compared to animal model testing (e.g. mice), this represents a significant breakthrough, that can be used to validate clinical development strategy and test efficacy in specific groups of patients. iPS is bringing a revolution in drug discovery methodology which is being used to bridge genetics, cell biology, and physiology.
Stem Cell Review: Biological Processes & Industrial Production (EP3) (22:49)
<all>What are the biological processes that stem cells go through? What are the industrial processes we need to manufacturing? What do we know about cancer stem cells? How do iPS cells fit into the picture vs. embryonic stem cells? In this episode we investigate how the science and research of stem cells is being translated into industrial cell processes to create FDA approvable, and commercializable products. Differentiation, proliferation, migration, retro-differentiation, trans-differentiation, transformation into cancer cells, the role of tumors' micro environments and epigenetics and all reviewed here by the field's foremost experts.
Stem Cell Review: Biological Processes & Industrial Productio...
Stem Cell Review: Allogeneic or Autologous? (EP2) (24:56)
<all>Reviewing the technology, business models, intellectual property, regulatory concerns, transplantation and immune rejection. This is the 2nd episode of the Stem Cell Review.
Stem Cell Review: Stem Cells at a Glance (EP1) (18:37)
<all>What are the different types of stem cells? Potential medical applications? Different business models? Ethical and political constraints? This 1st episode of the Stem Cell Review is a good introductory overview of stem cells.
Credits
In Order of Appearance:
GUESTS
Michael Schuster - Angioblast Systems, Inc. // Vice President, Operations
IMAGES
Stem Cell Review Studio Background Pictures provided by the California Institute of Regenerative Medicine
A Special Thanks to:
- Ferghana Partners Group
- ISSCR / The International Society for Stem Cell Research
- Genetics Policy Institute / World Stem Cell Summit
- Hilton Hotels / The Hilton Diagonal Mar in Barcelona
MUSIC
Protest by soundroll Five Tribes by ventilo35
Last but not Least!
- Freya Alugas
- Pat Becker
- Melissa Carpenter
- Ellen Charles
- Meagan Comerford
- Karena Essex
- Elisabet Fabregas
- Mario Fante
- Rocio Fontela
- Liz Freyn
- Don Gibbons
- Raj Kaur
- Paul Laland
- Gemma Llamas
- Jillian McFady
- Mary Lou McKeone
- Didier Montarras
- Mario Oliete
- Jose Maria Ruiz
- Valerie Tucker
- Kristen April Uekermann
- Nancy Witty
- Jessica Yingling
About
Acknowledgements
